Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Non-small Cell Lung Cancer (NSCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT03872661
What this trial is testing

Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC

Who this might be right for
Lung Cancer Stage III
Sun Yat-sen University 36
Testing effectiveness (Phase 2)Ended earlyNCT00271323
What this trial is testing

Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients

Who this might be right for
Non-Small-Cell Lung Carcinoma
Sanofi 14
Large-scale testing (Phase 3)Active Not RecruitingNCT04092283
What this trial is testing

Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+3 more
National Cancer Institute (NCI) 660
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07561983
What this trial is testing

Tislelizumab Plus Chemotherapy and BACE for Unresectable NSCLC

Who this might be right for
Unresectable Stage III Non-small Cell Lung CancerTislelizumabChemotherapy+2 more
Sichuan Cancer Hospital and Research Institute 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT06003231
What this trial is testing

Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

Who this might be right for
Carcinoma, Non-Small-Cell LungOvarian NeoplasmsEndometrial Neoplasms+1 more
Seagen, a wholly owned subsidiary of Pfizer 120
Testing effectiveness (Phase 2)Looking for participantsNCT05706129
What this trial is testing

Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)+6 more
Lumara Bio Oncologics GmbH 270
Early research (Phase 1)Study completedNCT04672434
What this trial is testing

Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 48
Not applicableActive Not RecruitingNCT05887011
What this trial is testing

CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia

Who this might be right for
Unresectable /Inoperable Locally Advanced (Stage II-III) NSCLC and Locally Advanced LS-SCLC (Stage I-III)
AstraZeneca 2,000
Not applicableStudy completedNCT04229381
What this trial is testing

Resiliency Among Older Adults Receiving Lung Cancer Treatment

Who this might be right for
Advanced Lung CarcinomaExtensive Stage Lung Small Cell CarcinomaStage IIIA Lung Cancer AJCC v8+6 more
Ohio State University Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)UnknownNCT01158144
What this trial is testing

Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)

Who this might be right for
Non-small Cell Lung Cancer
Zhejiang Cancer Hospital 134
Early research (Phase 1)Active Not RecruitingNCT04676477
What this trial is testing

HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Daiichi Sankyo 246
Not applicableActive Not RecruitingNCT05456867
What this trial is testing

A Multi-center, Non-interventional, Prospective Study of Durvalumab in Unresectable Locally Advanced NSCLC in Routine Clinical Practice in Russia

Who this might be right for
NSCLC, Non-small-cell Lung Carcinoma
AstraZeneca 250
Testing effectiveness (Phase 2)Study completedNCT01000480
What this trial is testing

Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07743723
What this trial is testing

IOV-5001 in Adults With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsNon-Small Cell Lung CancerTriple Negative Breast Cancer (TNBC)+4 more
Iovance Biotherapeutics, Inc. 106
Not applicableUnknownNCT04672759
What this trial is testing

A Real-world Study of Durvalumab for Lung Cancer in China

Who this might be right for
Non Small Cell Lung Cancer Stage IIISmall-Cell Lung Cancer
Peking Union Medical College Hospital 100
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT03625323
What this trial is testing

Combination Study With Soluble LAG-3 Fusion Protein Eftilagimod Alpha (IMP321) and Pembrolizumab in Patients With Previously Untreated Unresectable or Metastatic NSCLC, or Recurrent PD-X Refractory NSCLC or With Recurrent or Metastatic HNSCC

Who this might be right for
NSCLCHNSCC
Immutep S.A.S. 187
Testing effectiveness (Phase 2)Study completedNCT00356122
What this trial is testing

Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Sanofi 53
Testing effectiveness (Phase 2)Looking for participantsNCT06632262
What this trial is testing

Clinical Study of ABSK061 and ABSK043

Who this might be right for
HER2-Gastric/Gastroesophageal Junction CancerUrothelial CarcinomaNon-Small Cell Lung Cancer+1 more
Abbisko Therapeutics Co, Ltd 202
Large-scale testing (Phase 3)Looking for participantsNCT07131319
What this trial is testing

SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Second Affiliated Hospital of Nanchang University 30
Next Page